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Background: Terminal “QRS distortion” on the electrocardiogram (ECG) (based on Sclarovsky-
Birnbaum's Grades of Ischemia Score) is a sign of severe ischemia, associated with adverse 
cardiovascular outcome in ST-segment elevation myocardial infarction (STEMI). In addition, ECG 
indices of the acuteness of ischemia (based on Anderson-Wilkins Acuteness Score) indicate 
myocardial salvage potential. We assessed whether severe ischemia with or without acute ischemia 
is predictive of infarct size (IS), myocardial salvage index (MSI) and left ventricular ejection 
fraction (LVEF) in anterior versus inferior infarct locations.  
Methods: In STEMI patients, the severity and acuteness scores were obtained from the admission 
ECG. Based on the ECG patients were assigned with severe or non-severe ischemia and acute or 
non-acute ischemia. Cardiac magnetic resonance (CMR) was performed 2-6 days after primary 
percutaneous coronary intervention (pPCI). LVEF was measured by echocardiography 30 days after 
pPCI.  
Results: ECG analysis of 85 patients with available CMR resulted in 20 (23%) cases with severe 
and non-acute ischemia, 43 (51%) with non-severe and non-acute ischemia, 17 (20%) with non-
severe and acute ischemia, and 5 (6%) patients with severe and acute ischemia. In patients with 
anterior STEMI (n=35), ECG measures of severity and acuteness of ischemia identified significant 
and stepwise differences in myocardial damage and function. Patients with severe and non-acute 
ischemia had the largest IS, smallest MSI and lowest LVEF. In contrast, no difference was observed 
in patients with inferior STEMI (n=50).  
Conclusions: The applicability of ECG indices of severity and acuteness of myocardial ischemia to 
estimate myocardial damage and salvage potential in STEMI patients treated with pPCI, is confined 


















The acuteness-score, measured by the modified Anderson-Wilkins Acuteness Score, quantifies the 
acuteness of myocardial ischemia from the electrocardiogram (ECG) (1;2). In patients with ST-
segment elevation myocardial infarction (STEMI) treated with primary percutaneuous coronary 
intervention (pPCI), acute ischemia in their presenting ECG identifies salvage potential and predicts 
smaller infarct size independent of symptom durations (3-6). Distortion of the terminal portion of 
the QRS complexes in leads with ST elevation, due to myocardial vulnerability, has been defined as 
severe ischemia (7), is associated with rapid progression of necrosis and predicts adverse 
cardiovascular outcome (8-11). Thus, STEMI patients presenting with severe and acute ischemia on 
their ECG might particularly benefit from immediate coronary reperfusion. We assessed whether 
severe ischemia with or without acute ischemia is predictive of infarct size (IS), myocardial salvage 





Patients included in the MITOCARE study (12), a prospective, multicenter, randomized, double-
blind cardioprotection trial, were considered in the present study. In brief, the MITOCARE trial 
examined the potential for adjunctive TRO40303 to limit reperfusion injury in STEMI patients 
undergoing pPCI. Patients with first STEMI and symptom duration of <6 hours, underwent Cardiac 
Magnetic Resonance (CMR) imaging within 2 to 6 days after being treated with pPCI. In total, 165 

















angiography. The results demonstrated that TRO40303 did not limit reperfusion injury of the 
infarcted myocardium (13). 
 
ECG collection and ECG measurement 
Electrocardiograms were recorded at hospital admission (baseline ECG). The electrocardiographic 
analyses were performed in the ECG Core Laboratory at the Rigshospitalet (Copenhagen, 
Denmark). ST-segment deviation was measured manually to the nearest 0.5 mm at the J-point in all 
12 ECG leads using the TP-segment as the isoelectric line. Alternatively, the PR-segment was used 
if the TP-segment was not distinct. Patients with maximal ST elevation in leads V1 to V6 or I and 
aVL were classified as the anterior infarct group, while those with maximal ST elevation in leads II, 
III and aVF and/or ST-segment depression in V1-V3 were classified as the inferior infarct group.  
The ECG investigators were blinded to all patient data.  
 
The severity score 
Severity of ischemia was determined by Sclarovsky-Birnbaum's grades of ischemia, which is based 
on the presence or absence of distortion of the terminal portion of the QRS complex in leads with 
ST-segment elevation (14). Distortion of the terminal QRS complex was defined as: 1: Absence of 
an S-wave in ≥ 2 adjacent leads that usually have a terminal S configuration (leads V1 to V3); or 2: 
ST-J point amplitude ≥ 50% of the R-wave amplitude measured from the TP baseline in ≥ 2 
adjacent leads in all other leads. In addition, leads with ST-segment elevation and negative T-waves 


















We defined severe ischemia in the presence of QRS distortion in ≥2 contiguous leads and non-
severe ischemia in the absence of QRS distortion.   
 
The acuteness-score 
The ischemia acuteness-score was based on the modified Anderson-Wilkins acuteness score (1), 
which assesses changes in ST-T segments, T-waves and Q-waves. Each lead was designated an 
acuteness phase (1A, 1B, 2A or 2B) based on the presence or absence of a tall T-wave or an 
abnormal Q-wave; Phase 1A: tall T-wave and no abnormal Q-wave; Phase 1B: positive T-wave and 
no abnormal Q-wave; Phase 2A: tall T-wave and an abnormal Q-wave; Phase 2B: positive T-wave 
and an abnormal Q-wave (2). Criteria for abnormal Q-waves and tall T-waves are presented in table 
1. The acuteness-score ranges from 1 (non-acute ischemia/least acute) to 4 (early ischemia/most 
acute) and was calculated from the formula: 
Acuteness-score =
4(# 𝑙𝑒𝑎𝑑𝑠 1𝐴)+3(# 𝑙𝑒𝑎𝑑𝑠 1𝐵)+2(# 𝑙𝑒𝑎𝑑𝑠 2𝐴)+1(# 𝑙𝑒𝑎𝑑𝑠 2𝐵)
∑ # 𝑙𝑒𝑎𝑑𝑠 𝑤𝑖𝑡ℎ 1𝐴,1𝐵,2𝐴 𝑜𝑟 2𝐵
. 
Also, it has been shown that STEMI patients with ECG acuteness-score ≥3 and treated with pPCI, 
have better outcome independent of symptom durations (3;5;6). Accordingly, the ECG acuteness-
score was dichotomized as ≥3 and <3. We defined acute ischemia as ECG acuteness-score ≥3 and 
non-acute ischemia as ECG acuteness-score <3. 
 
ECG score analysis 


















All ECGs were analyzed manually by 3 investigators blinded to clinical, angiographic and CMR 
data as well as information on randomization arm. A manual non statistical reliability test was done 
by the ECG expert (MS) who controlled 25 random ECGs. No disagreements between the 3 
investigators and MS were observed. 
Patients were then stratified according to severity and acuteness scores in 4 ischemia groups. Severe 
and non-acute ischemia; Non-severe and non-acute ischemia; Non-severe and acute ischemia; and 
Severe and acute ischemia (Figure 1). 
 
 
CMR Image Acquisition and analysis 
Complete CMR examination was done in 93 patients. The CMR examinations were performed on a 
1.5 T system from either Philips (Philips Healthcare, Best, The Netherlands), Siemens (Siemens 
AG, Erlangen, Germany) or General Electrics (GE Healthcare, Fairfield). All subjects were placed 
in a supine position, and images were acquired at end-expiratory breath hold with ECG gating. 
Initial scout images were acquired to locate the heart. For assessment of myocardial area at risk 
(MaR) and left ventricular ejection fraction (LVEF), a short-axis multislice multiphase steady-state 
free precession (SSFP) sequence was applied ≈5 minutes after intravenous administration of a 
gadolinium-based extracellular contrast agent (0.2 mmol/kg) from base to apex. The slice thickness 
was 8 mm with no slice gap, and the in-plane resolution was typically 1.5×1.5 mm with a temporal 
resolution of 20 to 30 frames per cardiac cycle. Left ventricular endo- and epicardial borders were 
manually delineated in end-diastole and end-systole for assessment of end-diastolic volume (EDV) 

















risk was analyzed according to previously described methodology (16) and was expressed as % of 
left ventricle (LV). 
For infarct visualization, long- and short-axis late gadolinium enhancement (LGE) images covering 
the LV from base to apex were acquired ≈15 minutes after injection of gadolinium. The LGE 
images were acquired using an inversion-recovery gradient-recalled echo sequence with a slice 
thickness of 8 mm with no slice gap. In-plane resolution was typically 1.5×1.5 mm. Inversion time 
was adjusted to null the signal from viable myocardium (17). Infarct size (% of LV) was quantified 
according to previously described methodology taking partial volume effects into account (18). 
Microvascular obstruction (MVO) was defined as the hypo-enhanced myocardium within the 
hyper-enhanced regions of infarction and was expressed as % of LV.  
Myocardial salvage index was calculated as (MaR-IS)/MaR. LVEF was measured by 
echocardiography 30 days after pPCI. 
 
Biomarkers 
Serial Creatine Kinase Myocardial Band (CK-MB) and Troponin (Tn) T and I were measured by a 
core lab (Firalis SAS, Huningue, France, http://www.firalis.com) from blood samples taken before 
and after pPCI. Infarct size was biochemically estimated by peak CK-MB and peak TnT levels. 
 
Statistical analysis 
Categorical data are presented as numbers (percentages) and continuous data are reported as mean ± 




 interquartile). Baseline clinical and angiographic data were analyzed 

















groups. LV CMR measures and 30-day echocardiographic measures of LV were compared within 
the 4 ischemia groups for anterior vs. inferior STEMI. Groups were compared using Student’s t test 
or ANOVA. Variables not normally distributed were log transformed in analysis models, as 
appropriate. All tests were two-sided and the level of statistical significance was defined as p< 0.05. 





The ECG severity and acuteness-scores were measured in 147 and 165 patients, respectively. There 
were 86% male and mean age was 61 (±11) years old. Sixty five (40%) patients had anterior 
STEMI and 98 (60%) patients had non-anterior STEMI. Baseline characteristics according to 
patients with severe vs. non-severe ischemia and patients with acute vs. non-acute ischemia are 
shown in Table 2. 
 
LV outcomes according to electrocardiographic severity of ischemia 
LV outcome measures by biomarkers (n=161), CMR (n=93) and echocardiography (n=146) in 
patients with severe vs. non-severe ischemia and patients with acute vs. non-acute ischemia are 
shown in Table 3. Patients with severe ischemia had significantly larger infarct size estimated by 
peak CK-MB and CMR (21% (9-28) vs. 14% (10-19), p = 0.006) compared to those with non-
severe ischemia. MSI was significantly lower (50% (32-63) vs 56% (46-70), p = 0.035) in patients 

















had also a significant higher extent of MVO and lower LVEF measured by CMR. There was no 
difference in N-terminal pro-brain natriuretic peptide (NTproBNP) levels or LVEF at follow up 30 
days after pPCI in patients with severe vs. non-severe ischemia. 
 
LV outcomes according to electrocardiographic acuteness of ischemia 
 Patients with acute ischemia had smaller infarct size (10% (9-16) vs. 15% (10-25), p = 0.004) and 
larger MSI (61% (55-74) vs. 50% (10-25), p = 0.013) compared to those with non-acute ischemia. 
In addition, patients with acute ischemia had a significant higher LVEF (56% (51-64) vs. 52% (45-
56), p = 0.001) and two-fold lower levels of NTproBNP (p = 0.009) 30 days after pPCI, Table 3. 
 
LV outcomes according to combination of severity and acuteness of ischemia 
Four ECG ischemia groups were formed by combination of severity and acuteness-scores in 85 
patients with available CMR data and resulted in 20 (23%) cases with severe and non-acute 
ischemia, 43 (51%) with non-severe and non-acute ischemia, 17 (20%) with non-severe and acute 
ischemia, and 5 (6%) patients with severe and acute ischemia. LV outcome measures by 
biomarkers, CMR and echocardiography, across the ECG ischemia groups for anterior and non-
anterior STEMI are shown in Table 4.  
In patients with anterior STEMI, ECG measures of severity and acuteness of myocardial ischemia 
identified significant and stepwise differences in myocardial damage and function. Patients with 
severe ischemia and non-acute ischemia had the largest IS, smallest MSI and worst LVEF at follow 





















In the present study, we investigated the combination of the severity and acuteness of ischemia, 
obtained from admission ECG, in relation to left ventricular outcomes estimated by cardiac 
magnetic resonance in the acute phase, and by echocardiography 30 days after pPCI in patients with 
ST-segment elevation myocardial infarction. We demonstrated that patients with anterior STEMI 
and severe and non-acute ischemia on the admission ECG had the largest infarct size, smallest 
myocardial salvage and most impaired left ventricular function (Figure 2).  
 
Possible electrophysiological mechanisms of ECG patterns 
The process of evolving myocardial infarction begins rapidly after an acute coronary artery 
occlusion, where ischemia develops causing dynamic ECG changes. Initially tall T-waves develop. 
These are followed by evolvement of ST-segment elevation, abnormal Q-waves, T-wave inversion, 
and finally resolution of the ST-segment elevation. The changes reflect 1- presence, location and 
extent (ST-segment elevation), 2- severity (distortion of the terminal portion of the QRS) and 3- 
timing of the infarction process (tall T-waves versus abnormal Q-waves). In leads with ST-segment 
elevation, distortion of the terminal portion of the QRS are explained by prolongation of the 
electrical conduction in the purkinje fibers in the ischemic zone, resulting in increase of R-wave 
amplitude in leads with terminal R-wave ( I, II, III, aVL, aVF, V4-V6) and decrease in S-wave 
amplitude in leads with terminal S-wave (leads V1- V3). Because purkinje fibers are believed to be 

















is severe and prolonged, hence resulting in distortion of the terminal portion of the QRS complex 
(19). However, pre-disposing features of cardioprotection might have crucial role for protecting the 
jeopardized myocardium during the ischemic process. Several studies have demonstrated that 
patients with non-severe ischemia have higher incidence of collateral flow compared to patients 
with severe ischemia (19). Thus, absence of distortion of the terminal portion of the QRS complex, 
despite prolonged ischemia, might indicate myocardial protection (19). It has further been shown 
that distortion of the terminal portion of the QRS complex alongside with ST-segment elevation has 
been associated with larger infarct size and a rapid progression of myocardial necrosis over time 
(10). In addition, severe ischemia measured as distortion of the terminal portion of the QRS 
complex is an independent predictor of myocardial damage and clinical prognosis in STEMI 
patients (20). A faster (than recommended in guidelines) reperfusion strategy in these patients could 
therefore stop the progression of necrosis, thus salvage the jeopardized myocardium from 
infarction. However, since the myocardial infarction already has evolved in patients presenting with 
non-acute ischemia, a faster reperfusion strategy might only be beneficial in patients presenting 
with severe and acute ischemia on the ECG. The mechanism behind tall T-waves is not fully 
understood but a theory is that the repolarization of ischemic tissue is prolonged due to a delay in 
recovery of the membrane potential, which then causes tall T-waves (21). These changes are present 
temporarily after the onset of the infarction. Difference in gradients across the boundary between 
normal and ischemic myocardium changes the electrical currents in the myocardium causing ST-




















Time delays for reperfusion therapy 
Currently the triage for pPCI in STEMI is solely based on patient reported symptom durations. 
Primary PCI is the preferred choice of reperfusion therapy if it is provided within 60-90 minutes of 
first medical contact in STEMI patients with symptom duration <12 hours  (22-25). However, time 
of symptom onset estimation is often biased by inaccurate patient recollection and other factors that 
might pre-condition the ischemic myocardium leading to cardioprotection. The benefit from a faster 
reperfusion strategy by prehospital fibrinolysis has not been shown to be superior to pPCI in 
STEMI patients presenting early after symptom onset (26). Prehospital fibrinolysis is shown to be 
non-superior over pPCI in clinical trials. However, some patients may have great benefit from this 
early approach of reperfusion. In cases of severe ischemia the progression of necrosis is very rapid 
and the jeopardized myocardium might evolve faster to myocardial infarction in patients presenting 
with severe and acute ischemia on the ECG. Consequently, these patients might have outstanding 
benefits from prehospital fibrinolysis, which basically reduces ischemia duration significantly, in 
addition to achieving reperfusion of the culprit artery onsite. Our findings illustrate that the 
combined application of ECG scores of the severity and acuteness of myocardial ischemia from the 
ECG is a useful clinical tool that identifies patients with severe and acute ischemia, who may 
potentially have the most benefit for a faster reperfusion strategy. More research is warranted to 
confirm this hypothesis. Severity score and acuteness-scores of myocardial ischemia from the 
prehospital ECG may be of value as a stratification and inclusion parameter in designing future 




















The present study has several limitations. Since this study was a sub-study from the MITOCARE 
trial, the study population is considered relatively small sized when stratified in 4 ECG groups. In 
the severe and acute ischemia group, there were no patients with anterior infarction. Thus, the 
analysis was based on the remaining 3 ECG groups in the anterior infarction group. Larger studies 
will be of great value, providing results based on statistical tests within the 4 groups. ECGs were 
analyzed manually by 3 independent investigators and no statistical reliability was performed. 
However, a forth investigator (MS) has manually controlled 25 random ECGs, without finding any 
discrepancies between the investigators and MS. Due to the complexity of the ECG scores and 
availability of digital ECG, development of the automatic algorithms for acuteness-score (28) and 
severity of ischemia could facilitate clinical applications of these scores.  
 
Conclusion 
The applicability of ECG indices of severity and acuteness of myocardial ischemia to estimate 
myocardial damage and salvage potential in STEMI patients treated with pPCI, is confined to 
anterior myocardial infarction. 
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Figure 1: Stratification of patients according to severity and acuteness of ischemia from the 
admission electrocardiogram (25mm/s, 10mm/mV, 150Hz). A: Severe and non-acute ischemia: 
Severe ischemia due to terminal QRS distortion in V2-V4 and non-acute ischemia due to acuteness-
score <3. B: Non-severe and non-acute ischemia: No terminal QRS distortion in leads with ST-
segment elevation and acuteness-score <3. C: Non-severe and acute ischemia: No terminal QRS 
distortion in leads with ST-segment elevation and acuteness-score >3. D: Severe and acute 
ischemia: Terminal QRS distortion in > 2 leads with ST-segment elevation (V2-V4) and acuteness-
score >3. 
 
Figure 2: Median left ventricular cardiac magnetic resonance and echocardiographic measures 
according to combination of electrocardiographic severity and acuteness of ischemia. 






















































Table 1 Lead specific criteria for abnormal Q-waves and tall T-waves 
Lead Abnormal Q-wave Tall T-wave 
I ≥30 ms ≥0.50 mV 
II ≥30 ms ≥0.50 mV 
III ≥ 30 ms and abnormal Q in aVF ≥0.25 mV 
aVR – – 
aVL ≥30 ms ≥0.25 mV 
aVF ≥30 ms ≥0.50 mV 
V1 Any Q-wave ≥0.50 mV 
V2 Any Q-wave ≥1.0 mV 
V3 Any Q-wave ≥1.0 mV 
V4 ≥30 ms ≥1.0 mV 
V5 ≥30 ms ≥0.75 mV 
V6 ≥30 ms ≥0.50 mV 


















Table 2: Baseline characteristics according to electrocardiographic ischemia scores 
 Electrocardiographic severity of ischemia  
Patient characteristics Severe ischemia 
(n = 41 ) 
Non-severe ischemia 
(n = 106) 
p-value 
Age, years  63 ±11 60 ±11 0.203 
Male gender 34 (83) 92 (87) 0.548 
Smoker 19 (46) 44 (42) 0.596 
Hypertension 14 (34) 29 (27) 0.417 
Diabetes mellitus 1 (2) 10 (9) 0.148 
Killip class>1 32 (94) 68 (96) 0.709 
Symptom to ballon inflation, min 200 (157-253) 173 (146-228) 0.229 
   
Angiographic data   
Culprit vessel   0.330 
LAD 12 (29) 43 (41)  
RCA 22 (54) 52 (49)  
LCX 7 (17) 11 (10)  
    
TIMI flow before pPCI   
0.809 0 37 (90) 97 (92) 
1 4 (10) 9 (8) 
TIMI flow after pPCI   
0.878 2 3 (7) 4 (4) 
3 34 (83) 90 (85) 
Treatment (TRO40303) 23 (56%) 50 (49%) 0.463 
 

















Patient characteristics Acute ischemia 
(n = 41 ) 
non-acute ischemia 
(n = 124 ) 
p-value 
Age, years  57±11 64±11 0.003 
Male gender 35 (85) 103 (83) 0.729 
Smoker 18 (44) 81 (65) 0.015 
Hypertension 12 (29) 36 (29) 0.977 
Diabetes mellitus 1 (2) 11 (9) 0.169 
Killip class>1 26 (100) 89 (93) 0.189 
Symptom to ballon inflation, min 167 (128-230) 184 (159-252) 0.099 
   
Angiographic data   
Culprit vessel   
0.403 
LAD 14 (34) 48 (39) 
RCA 19 (46) 62 (50) 
LCX 8 (20) 14 (11) 
   
TIMI flow before pPCI   
0.425 0 36 (88) 114 (92) 
1 5 (12) 10 (8) 
TIMI flow after pPCI   
0.836 2 1 (2) 7 (6) 
3 35 (85) 105 (85) 
Treatment (TRO40303) 19 (48%) 64 (52%) 0.716 
Values are given in n (%), mean (±SD) or median (interquartile range). 
LAD, Left Anterior Descending coronary artery; LXC, Left Circumflex coronary artery; RCA, Right Coronary Artery; pPCI, 



















Table 3: Left ventricular measures according to electrocardiographic ischemia scores 




n = 41 
Non-severe ischemia 
n = 106 
p-value 
TNTmax 9647 (6084 – 19502) 10003 (5406 – 15042) 0.375 
CK-MBmax 268 (172 – 434) 175 (73-273) 0.001 
NTproBNP at baseline 85 (61-193) 77 (44-180) 0.812 
   
CMR data (n = 85) n = 25 n = 60  
Infarct transmurality % 80 (68-86) 75 (64-82) 0.162 
MVO % 0.04 (0-7) 0.01 (0-0.9) 0.001 
LVEF % 43 (41-50) 50 (43-55) 0.002 
MAR % 37 (27-49) 33 (28-39) 0.019 
IS % 21 (9-28) 14 (10-19) 0.006 
MSI % 50 (32-63) 56 (46-70) 0.035 
    
30-day follow-up n = 37 n = 89  
LVEF* 50 (44-58) 53 (47-59) 0.077 
NTproBNP 1037 (513-1815) 588 (366-1049) 0.156 
 




n = 41 
Non-acute ischemia 
n = 120 
p-value 
TNTmax 7662 (4742-12554) 9988 (6553-17788) 0.266 
CK-MBmax 156 (71-261) 197 (84-334) 0.092 

















   
CMR data n = 22 n = 71  
Infarct transmurality % 73 (56-80) 78 (67-85) 0.036 
MVO % 0.005 (0-0.01) 0.04 (0-2) 0.074 
LVEF % 52 (45-55) 48 (42-53) 0.065 
MAR % 31 (24-37) 35 (28-42) 0.028 
IS % 10 (9-16) 15 (10-25) 0.004 
MSI % 61 (55-74) 50 (43-63) 0.013 
    
30-day follow-up n = 36 n = 103  
LVEF* 56 (51-64) 52 (45-56) 0.001 
NTproBNP 424 (234-728) 819 (463-1745) 0.009 
Values are given in median (interquartile range).  
TNTmax; Peak Troponin T, CK-MBmax; Peak Creatinine Kinase Myocardial Band, MVO; Microvascular Obstruction, LVEF; Left 
Ventricular Ejection Fraction, MAR; Myocardial Area at Risk, IS; Infarct Size, MSI; Myocardial Salvage Index. NTproBNP; N-
terminal pro-brain natriuretic peptide  



















Table 4: Left ventricular measures according to combination of electrocardiographic severity and 
acuteness of ischemia 
Anterior STEMI Combination of ECG severity and acuteness of ischemia  
 Severe and 
non-acute 
ischemia 




























131 (30-260) - 0.008 
CMR data n = 10 n = 17 n = 8 n = 0  











































































Non-Anterior STEMI      
Biomarkers n = 19 n = 40  n = 17 n = 9 p-value 



















CMR data n = 10  n = 26 n = 9 n = 5  























































30-day follow-up n = 18  n = 33 n = 16 n = 7  


























(420-1967) (282-1005) (180-577) (282-929) 
Values are given in median (interquartile range).  
TNTmax; Peak Troponin T, CK-MBmax; Peak CKMB, MVO; Microvascular Obstruction, LVEF; Left Ventricular Ejection 





















- STEMI patients treated with primary PCI 
- Terminal portion of QRS as severe ischemia according to Sclarovsky-Birnbaum grades of ischemia 
- Ischemia acuteness assessed from admission ECG according to Anderson-Wilkin acuteness of 
ischmia 
- Severe and non-acute ischemia from ECG was associated with damage of myocardium by CMR 
